世界卫生组织发布《2026年全球结核病报告》,指出2025年中国估算结核病新发患者数为68.5万,较2024年的69.6万有所下降 1。同年,中国估算结核病死亡人数为2.6万,低于2024年的2.8万,发病率为48/10万 1。数据显示,中国已实现结核病死亡数较2015年下降35%,达成“终结结核病流行策略”设定的第一个(2020年)里程碑目标 1。
全球方面,2025年估算新发结核病患者达1060万,因结核病死亡约113万 1。尽管全球结核病发病率在2015年至2025年间净下降14%,但防控形势依然严峻 1。目前全球面临的主要挑战包括巨大的诊断治疗缺口、耐药性问题以及研究资金不足等 1。具体而言,2025年全球有220万结核病患者未得到诊断或未被报告 1;2023年结核病研究资金为12亿美元,不到2027年每年50亿美元目标额的四分之一 1。世卫组织总干事谭德塞敦促各国紧急扩大防治服务可及性并保障必要供资 1。
The World Health Organization released the "Global Tuberculosis Report 2026," estimating that China recorded 685,000 new tuberculosis cases and 26,000 deaths in 2025 1. This represents a decrease from the 696,000 cases and 28,000 deaths reported in 2024, resulting in an incidence rate of 48 per 100,000 people in 2025 1. By achieving a 35% reduction in tuberculosis-related deaths compared to 2015 levels, China has met the first milestone target (for 2020) of the End TB Strategy 1.
Globally, there were approximately 10.6 million new tuberculosis cases and 1.13 million deaths in 2025 1. Although the global incidence rate decreased by a net 14% between 2015 and 2025, significant challenges remain, including an estimated 2.2 million undiagnosed or unreported cases worldwide in 2025 1. Additionally, funding for tuberculosis research stood at $1.2 billion in 2023, which is less than one-quarter of the annual $5 billion target set for 2027 1. WHO Director-General Tedros Adhanom Ghebreyesus urged countries to urgently expand access to prevention and treatment services while ensuring adequate funding 1.
评论
还没有评论,欢迎留下第一条。